Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 64


Development and comparative evaluation of two antigen detection tests for Visceral Leishmaniasis.

Vallur AC, Tutterrow YL, Mohamath R, Pattabhi S, Hailu A, Abdoun AO, Ahmed AE, Mukhtar M, Salam MA, Almeida ML, Almeida RP, Mondal D, Albertini A, Ghalib H, Duthie MS, Reed SG.

BMC Infect Dis. 2015 Sep 22;15(1):384. doi: 10.1186/s12879-015-1125-3.


Alterations to antigen-specific immune responses before and after multidrug therapy of leprosy.

Freitas AA, Oliveira RM, Hungria EM, Cardoso LP, Sousa AL, Costa MB, Reed SG, Duthie MS, Stefani MM.

Diagn Microbiol Infect Dis. 2015 Oct;83(2):154-61. doi: 10.1016/j.diagmicrobio.2015.06.021. Epub 2015 Jul 2.


From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE.

Coler RN, Duthie MS, Hofmeyer KA, Guderian J, Jayashankar L, Vergara J, Rolf T, Misquith A, Laurance JD, Raman VS, Bailor HR, Cauwelaert ND, Reed SJ, Vallur A, Favila M, Orr MT, Ashman J, Ghosh P, Mondal D, Reed SG.

Clin Transl Immunology. 2015 Apr 10;4(4):e35. doi: 10.1038/cti.2015.6. eCollection 2015 Apr.


Antigen-specific assessment of the immunological status of various groups in a leprosy endemic region.

da Conceição Oliveira Coelho Fabri A, Carvalho AP, Araujo S, Goulart LR, de Mattos AM, Teixeira HC, Goulart IM, Duthie MS, Correa-Oliveira R, Lana FC.

BMC Infect Dis. 2015 May 30;15:218. doi: 10.1186/s12879-015-0962-4.


Specific antibody responses as indicators of treatment efficacy for visceral leishmaniasis.

Vallur AC, Hailu A, Mondal D, Reinhart C, Wondimu H, Tutterrow Y, Ghalib HW, Reed SG, Duthie MS.

Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):679-86. doi: 10.1007/s10096-014-2282-9. Epub 2014 Nov 19.


Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-γ.

Desbien AL, Reed SJ, Bailor HR, Dubois Cauwelaert N, Laurance JD, Orr MT, Fox CB, Carter D, Reed SG, Duthie MS.

Eur J Immunol. 2015 Feb;45(2):407-17. doi: 10.1002/eji.201444543. Epub 2014 Dec 3.


Interleukin 17A acts synergistically with interferon γ to promote protection against Leishmania infantum infection.

Nascimento MS, Carregaro V, Lima-Júnior DS, Costa DL, Ryffel B, Duthie MS, de Jesus A, de Almeida RP, da Silva JS.

J Infect Dis. 2015 Mar 15;211(6):1015-26. doi: 10.1093/infdis/jiu531. Epub 2014 Oct 1.


Evaluation of novel tools to facilitate the detection and characterization of leprosy patients in China.

Wen Y, You YG, Yuan LC, Yuan YH, Zhang Y, Duthie MS, Li HY.

Biomed Res Int. 2014;2014:371828. doi: 10.1155/2014/371828. Epub 2014 Aug 12.


Protection against Mycobacterium leprae infection by the ID83/GLA-SE and ID93/GLA-SE vaccines developed for tuberculosis.

Duthie MS, Coler RN, Laurance JD, Sampaio LH, Oliveira RM, Sousa AL, Stefani MM, Maeda Y, Matsuoka M, Makino M, Reed SG.

Infect Immun. 2014 Sep;82(9):3979-85. doi: 10.1128/IAI.02145-14. Epub 2014 Jul 14.


Utility of recombinant proteins LID-1 and PADL in screening for Mycobacterium leprae infection and leprosy.

de Souza MM, Netto EM, Nakatani M, Duthie MS.

Trans R Soc Trop Med Hyg. 2014 Aug;108(8):495-501. doi: 10.1093/trstmh/tru093. Epub 2014 Jun 7.


A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7.

Fox CB, Sivananthan SJ, Duthie MS, Vergara J, Guderian JA, Moon E, Coblentz D, Reed SG, Carter D.

J Nanobiotechnology. 2014 Apr 26;12:17. doi: 10.1186/1477-3155-12-17.


A rapid ELISA for the diagnosis of MB leprosy based on complementary detection of antibodies against a novel protein-glycolipid conjugate.

Duthie MS, Raychaudhuri R, Tutterrow YL, Misquith A, Bowman J, Casey A, Balagon MF, Maghanoy A, Beltran-Alzate JC, Romero-Alzate M, Cardona-Castro N, Reed SG.

Diagn Microbiol Infect Dis. 2014 Jun;79(2):233-9. doi: 10.1016/j.diagmicrobio.2014.02.006. Epub 2014 Feb 24.


Synergistic antigen combinations for the development of interferon gamma release assays for paucibacillary leprosy.

Oliveira RM, Hungria EM, de Araújo Freitas A, de Sousa AL, Costa MB, Reed SG, Duthie MS, Stefani MM.

Eur J Clin Microbiol Infect Dis. 2014 Aug;33(8):1415-24. doi: 10.1007/s10096-014-2077-z. Epub 2014 Mar 12.


Micronutrients influencing the immune response in leprosy.

Passos Vázquez CM, Mendes Netto RS, Ferreira Barbosa KB, Rodrigues de Moura T, de Almeida RP, Duthie MS, Ribeiro de Jesus A.

Nutr Hosp. 2014 Jan 1;29(1):26-36. doi: 10.3305/nh.2014.29.1.6988.


Rapid quantitative serological test for detection of infection with Mycobacterium leprae, the causative agent of leprosy.

Duthie MS, Balagon MF, Maghanoy A, Orcullo FM, Cang M, Dias RF, Collovati M, Reed SG.

J Clin Microbiol. 2014 Feb;52(2):613-9. doi: 10.1128/JCM.02085-13. Epub 2013 Dec 11.


Optimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activity.

Fung HW, Mikasa TJ, Vergara J, Sivananthan SJ, Guderian JA, Duthie MS, Vedvick TS, Fox CB.

J Nanobiotechnology. 2013 Dec 21;11:43. doi: 10.1186/1477-3155-11-43.


Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis.

Vallur AC, Duthie MS, Reinhart C, Tutterrow Y, Hamano S, Bhaskar KR, Coler RN, Mondal D, Reed SG.

Clin Microbiol Infect. 2014 Jun;20(6):O374-83. doi: 10.1111/1469-0691.12421. Epub 2013 Nov 18.


Alteration of the serum biomarker profiles of visceral leishmaniasis during treatment.

Duthie MS, Guderian J, Vallur A, Bhatia A, Lima dos Santos P, Vieira de Melo E, Ribeiro de Jesus A, Todt M, Mondal D, Almeida R, Reed SG.

Eur J Clin Microbiol Infect Dis. 2014 Apr;33(4):639-49. doi: 10.1007/s10096-013-1999-1. Epub 2013 Oct 31.


Development of a quantitative rapid diagnostic test for multibacillary leprosy using smart phone technology.

Paula Vaz Cardoso L, Dias RF, Freitas AA, Hungria EM, Oliveira RM, Collovati M, Reed SG, Duthie MS, Martins Araújo Stefani M.

BMC Infect Dis. 2013 Oct 23;13:497. doi: 10.1186/1471-2334-13-497.


High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis.

de Oliveira FA, Vanessa Oliveira Silva C, Damascena NP, Passos RO, Duthie MS, Guderian JA, Bhatia A, de Moura TR, Reed SG, de Almeida RP, de Jesus AR.

BMC Infect Dis. 2013 Jul 19;13:331. doi: 10.1186/1471-2334-13-331.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk